Different course of reactive arthritis in two HLA-B27 positive brotherswith fatal outcome in one

xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns="http://www.w3.org/TR/REC-html40"> Different course of reactive arthritis in two HLA-B27 positive brothers with fatal outcome in one

http://navigation.helper.realnames.com/framer/1/262/default.asp?realname=PubMed&url=http%3A%2F%2Fwww%2Encbi%2Enlm%2Enih%2Egov%2FPubMed%2F&frameid=1&providerid=262&uid=30005730

 

J Rheumatol 1997 Oct;24(10):2047-2050

Related Articles, Books, LinkOut


Different course of reactive arthritis in two HLA-B27 positive brothers with fatal outcome in one.

Yli-Kerttula T, Mottonen T, Toivanen A.

Department of Medicine, Turku University, Finland.

During an outbreak of Yersinia pseudotuberculosis III, one of two HLA-B27 positive brothers developed reactive arthritis (ReA), mild at first, but later severely destructive and ultimately fatal. The reactivation of ReA was possibly triggered by an oral polio vaccine. The cause of death was severe secondary amyloidosis. The other brother was exposed to the same Y. pseudotuberculosis strain but did not develop any disease during or after the outbreak. However, he later developed ReA due to a Salmonella infection, with a benign course.

PMID: 9330954 [PubMed - indexed for MEDLINE]

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.